A case of severe cerebral embolism after chemotherapy for HER2-positive gastric cancer

BACKGROUND: Trastuzumab + chemotherapy is considered the standard therapy for advanced human epidermal growth factor receptor 2 (HER2)-positive gastric cancer with mild manageable toxicity, on the basis of the results of a pivotal phase-III trial. Cerebrovascular events are not recognized as expecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahama, Takayuki, Takeda, Masayuki, Nishina, Shinichi, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379602/
https://www.ncbi.nlm.nih.gov/pubmed/25885256
http://dx.doi.org/10.1186/s13104-015-1059-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379602/
https://www.ncbi.nlm.nih.gov/pubmed/25885256
http://dx.doi.org/10.1186/s13104-015-1059-2

Ejemplares similares